Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$9.30
0.252.76%
At close: -
$9.70
0.404.30%
After Hours: 4:37 PM EDT
Comments
Loading...
Syndax Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:SNDX | Benzinga
Syndax Pharmaceuticals Inc has a consensus price target of $35.81 based on the ratings of 16 analysts. The high is $51 issued by HC Wainwright & Co. on March 4, 2025. The low is $17 issued by Scotiabank on May 6, 2025. The 3 most-recent analyst ratings were released by Scotiabank, Guggenheim, and JP Morgan on May 6, 2025, May 6, 2025, and March 20, 2025, respectively. With an average price target of $30 between Scotiabank, Guggenheim, and JP Morgan, there's an implied 209.28% upside for Syndax Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Scotiabank
Guggenheim
JP Morgan
Citigroup
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Syndax Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/06/2025 | Buy Now | 75.26% | Scotiabank | George Farmer38% | $16 → $17 | Maintains | Sector Perform | Get Alert |
| 05/06/2025 | Buy Now | 229.9% | Guggenheim | Michael Schmidt54% | $32 → $32 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2025 | Buy Now | 322.68% | JP Morgan | Anupam Rama56% | $39 → $41 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 302.06% | JP Morgan | Anupam Rama56% | $35 → $39 | Maintains | Overweight | Get Alert |
| 03/04/2025 | Buy Now | 332.99% | Citigroup | Yigal Nochomovitz53% | $45 → $42 | Maintains | Buy | Get Alert |
| 03/04/2025 | Buy Now | 425.77% | HC Wainwright & Co. | Edward White45% | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 01/08/2025 | Buy Now | 64.95% | Scotiabank | George Farmer38% | $18 → $16 | Maintains | Sector Perform | Get Alert |
| 12/10/2024 | Buy Now | 425.77% | HC Wainwright & Co. | Edward White45% | $51 → $51 | Reiterates | Buy → Buy | Get Alert |
| 11/21/2024 | Buy Now | 291.75% | JP Morgan | Anupam Rama56% | $33 → $38 | Maintains | Overweight | Get Alert |
| 11/19/2024 | Buy Now | 363.92% | Citigroup | Yigal Nochomovitz53% | $37 → $45 | Maintains | Buy | Get Alert |
| 11/18/2024 | Buy Now | 425.77% | HC Wainwright & Co. | Edward White45% | $49 → $51 | Maintains | Buy | Get Alert |
| 11/12/2024 | Buy Now | 405.15% | HC Wainwright & Co. | Edward White45% | $47 → $49 | Maintains | Buy | Get Alert |
| 11/07/2024 | Buy Now | 240.21% | Goldman Sachs | Chris Shibutani54% | $30 → $33 | Maintains | Buy | Get Alert |
| 11/06/2024 | Buy Now | 384.54% | HC Wainwright & Co. | Edward White45% | $45 → $47 | Maintains | Buy | Get Alert |
| 10/24/2024 | Buy Now | 281.44% | UBS | David Dai25% | → $37 | Initiates | → Buy | Get Alert |
| 10/14/2024 | Buy Now | 322.68% | Stifel | Bradley Canino39% | $40 → $41 | Maintains | Buy | Get Alert |
| 08/16/2024 | Buy Now | 250.52% | Citigroup | Yigal Nochomovitz53% | $30 → $34 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 363.92% | HC Wainwright & Co. | Edward White45% | $41 → $45 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 219.59% | B of A Securities | Jason Zemansky68% | $30 → $31 | Maintains | Buy | Get Alert |
| 08/15/2024 | Buy Now | 240.21% | Barclays | Peter Lawson40% | $32 → $33 | Maintains | Overweight | Get Alert |
| 08/06/2024 | Buy Now | 240.21% | JP Morgan | Anupam Rama56% | $34 → $33 | Maintains | Overweight | Get Alert |
| 08/02/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 07/30/2024 | Buy Now | 209.28% | B of A Securities | Jason Zemansky68% | $31 → $30 | Maintains | Buy | Get Alert |
| 07/29/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 06/28/2024 | Buy Now | 281.44% | Jefferies | Kelly Shi38% | → $37 | Initiates | → Buy | Get Alert |
| 06/26/2024 | Buy Now | 332.99% | Stifel | Bradley Canino39% | $40 → $42 | Maintains | Buy | Get Alert |
| 06/17/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 05/21/2024 | Buy Now | 250.52% | JP Morgan | Anupam Rama56% | $34 → $34 | Maintains | Overweight | Get Alert |
| 05/09/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 05/09/2024 | Buy Now | 209.28% | Citigroup | Yigal Nochomovitz53% | $32 → $30 | Maintains | Buy | Get Alert |
| 05/09/2024 | Buy Now | 312.37% | Stifel | Bradley Canino39% | $39 → $40 | Maintains | Buy | Get Alert |
| 04/26/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 03/27/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Maintains | Buy | Get Alert |
| 03/20/2024 | Buy Now | 250.52% | JP Morgan | Anupam Rama56% | $31 → $34 | Maintains | Overweight | Get Alert |
| 02/28/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | → $41 | Reiterates | Buy → Buy | Get Alert |
| 01/31/2024 | Buy Now | 137.11% | Scotiabank | George Farmer38% | $36 → $23 | Downgrade | Sector Outperform → Sector Perform | Get Alert |
| 01/02/2024 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $41 → $41 | Reiterates | Buy → Buy | Get Alert |
| 12/22/2023 | Buy Now | 322.68% | HC Wainwright & Co. | Edward White45% | $42 → $41 | Maintains | Buy | Get Alert |
| 12/22/2023 | Buy Now | 363.92% | Mizuho | Mara Goldstein56% | → $45 | Initiates | → Buy | Get Alert |
| 10/26/2023 | Buy Now | 271.13% | Stifel | Bradley Canino39% | $38 → $36 | Maintains | Buy | Get Alert |
| 10/25/2023 | Buy Now | 198.97% | B of A Securities | Jason Zemansky68% | → $29 | Initiates | → Buy | Get Alert |
| 10/17/2023 | Buy Now | 291.75% | JP Morgan | Anupam Rama56% | $36 → $38 | Maintains | Overweight | Get Alert |
| 10/11/2023 | Buy Now | 209.28% | Goldman Sachs | Chris Shibutani54% | → $30 | Initiates | → Buy | Get Alert |
| 10/03/2023 | Buy Now | 188.66% | Baird | Joel Beatty65% | $32 → $28 | Maintains | Outperform | Get Alert |
| 10/02/2023 | Buy Now | 332.99% | HC Wainwright & Co. | Edward White45% | $38 → $42 | Reiterates | Buy → Buy | Get Alert |
| 08/16/2023 | Buy Now | 240.21% | JP Morgan | Anupam Rama56% | $36 → $33 | Maintains | Overweight | Get Alert |
| 08/04/2023 | Buy Now | 291.75% | HC Wainwright & Co. | Edward White45% | → $38 | Reiterates | → Buy | Get Alert |
| 07/27/2023 | Buy Now | 302.06% | Scotiabank | George Farmer38% | → $39 | Initiates | → Sector Outperform | Get Alert |
| 07/26/2023 | Buy Now | 260.82% | Citigroup | Yigal Nochomovitz53% | $31 → $35 | Maintains | Buy | Get Alert |
| 07/26/2023 | Buy Now | 250.52% | Barclays | Peter Lawson40% | $31 → $34 | Maintains | Overweight | Get Alert |
| 07/25/2023 | Buy Now | 332.99% | Guggenheim | Michael Schmidt54% | $40 → $42 | Maintains | Buy | Get Alert |
| 07/25/2023 | Buy Now | 271.13% | B. Riley Securities | Kalpit Patel39% | $34 → $36 | Maintains | Buy | Get Alert |
| 07/24/2023 | Buy Now | 291.75% | HC Wainwright & Co. | Edward White45% | $36 → $38 | Reiterates | Buy → Buy | Get Alert |
| 07/11/2023 | Buy Now | 312.37% | Guggenheim | Michael Schmidt54% | → $40 | Initiates | → Buy | Get Alert |
| 06/26/2023 | Buy Now | 260.82% | BTIG | Justin Zelin39% | $34 → $35 | Maintains | Buy | Get Alert |
| 05/10/2023 | Buy Now | 219.59% | Citigroup | Yigal Nochomovitz53% | $32 → $31 | Maintains | Buy | Get Alert |
| 05/09/2023 | Buy Now | 271.13% | HC Wainwright & Co. | Edward White45% | $33 → $36 | Maintains | Buy | Get Alert |
| 03/07/2023 | Buy Now | 271.13% | JP Morgan | Anupam Rama56% | $41 → $36 | Maintains | Overweight | Get Alert |
| 03/02/2023 | Buy Now | 229.9% | Citigroup | Yigal Nochomovitz53% | $29 → $32 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 250.52% | Goldman Sachs | Madhu Kumar72% | $39 → $34 | Maintains | Buy | Get Alert |
| 03/01/2023 | Buy Now | 240.21% | HC Wainwright & Co. | Edward White45% | → $33 | Reiterates | → Buy | Get Alert |
| 01/31/2023 | Buy Now | 281.44% | Stifel | Bradley Canino39% | → $37 | Initiates | → Buy | Get Alert |
| 01/03/2023 | Buy Now | 322.68% | JP Morgan | Anupam Rama56% | → $41 | Initiates | → Overweight | Get Alert |
| 12/12/2022 | Buy Now | 302.06% | Goldman Sachs | Madhu Kumar72% | $35 → $39 | Maintains | Buy | Get Alert |
| 12/12/2022 | Buy Now | 240.21% | HC Wainwright & Co. | Edward White45% | $31 → $33 | Maintains | Buy | Get Alert |
| 08/09/2022 | Buy Now | 260.82% | Goldman Sachs | Madhu Kumar72% | $40 → $35 | Maintains | Buy | Get Alert |
| 07/28/2022 | Buy Now | 219.59% | B. Riley Securities | Kalpit Patel39% | → $31 | Reinstates | → Buy | Get Alert |
| 05/24/2022 | Buy Now | 312.37% | Goldman Sachs | Madhu Kumar72% | $51 → $40 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Syndax Pharmaceuticals (SNDX) stock?
The latest price target for Syndax Pharmaceuticals (NASDAQ:SNDX) was reported by Scotiabank on May 6, 2025. The analyst firm set a price target for $17.00 expecting SNDX to rise to within 12 months (a possible 75.26% upside). 29 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Syndax Pharmaceuticals (SNDX)?
The latest analyst rating for Syndax Pharmaceuticals (NASDAQ:SNDX) was provided by Scotiabank, and Syndax Pharmaceuticals maintained their sector perform rating.
When was the last upgrade for Syndax Pharmaceuticals (SNDX)?
There is no last upgrade for Syndax Pharmaceuticals
When was the last downgrade for Syndax Pharmaceuticals (SNDX)?
The last downgrade for Syndax Pharmaceuticals Inc happened on January 31, 2024 when Scotiabank changed their price target from $36 to $23 for Syndax Pharmaceuticals Inc.
When is the next analyst rating going to be posted or updated for Syndax Pharmaceuticals (SNDX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Syndax Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Syndax Pharmaceuticals was filed on May 6, 2025 so you should expect the next rating to be made available sometime around May 6, 2026.
Is the Analyst Rating Syndax Pharmaceuticals (SNDX) correct?
While ratings are subjective and will change, the latest Syndax Pharmaceuticals (SNDX) rating was a maintained with a price target of $16.00 to $17.00. The current price Syndax Pharmaceuticals (SNDX) is trading at is $9.70, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
